XP impaired the activation of hematopoietic stem-progenitor cells (HSPCs) as well as the differentiation of HSPCs into MDSCs through TAMs/CXCL1 signaling pathway to inhibit lung metastasis of breast cancer (25). Here, CXCL1 is linked to breast carcinoma.